Literature DB >> 24783016

The vitamin d receptor in thyroid development and function.

Isabelle Clinckspoor1, Anne-Catherine Gérard2, Jacqueline Van Sande3, Marie-Christine Many2, Lieve Verlinden1, Roger Bouillon1, Geert Carmeliet1, Chantal Mathieu4, Annemieke Verstuyf1, Brigitte Decallonne4.   

Abstract

BACKGROUND AND
OBJECTIVE: Vitamin D is known to modulate thyroid neoplastic and autoimmune disease. We investigated the role of the vitamin D receptor (VDR) in normal thyroid development and function (thyrocytes and C cells).
METHODS: The thyroid phenotype of VDR knockout mice was studied in comparison to wild-type controls. The mice were fed a normal diet or a calcium-rich diet to circumvent effects induced by hypocalcemia.
RESULTS: Thyroid morphology was unaltered in VDR knockout mice. Also, expression of different parameters of thyrocyte function was comparable (immunohistochemistry). C cell physiology was, however, affected in the absence of the VDR, resulting in increased thyroidal calcitonin expression (immunohistochemistry), paralleled by increased serum calcitonin levels, but only in normocalcemic mice. To study a possible effect of vitamin D status on basal calcitonin levels in humans, serum calcitonin concentrations were compared between vitamin D-deficient and -sufficient patients (serum 25-OH vitamin D3 ≤10 and ≥40 ng/ml, respectively), but no difference was observed.
CONCLUSIONS: In mice, the VDR is redundant for normal thyrocyte function, but not for C cell function, where it mediates the negative control of calcitonin by 1,25-dihydroxyvitamin D3. In patients, vitamin D status does not affect basal serum calcitonin levels. A study in healthy individuals is needed to confirm these findings.

Entities:  

Keywords:  Calcitonin; Calcium; Thyroid; Vitamin D; Vitamin D receptor

Year:  2012        PMID: 24783016      PMCID: PMC3821476          DOI: 10.1159/000342363

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  33 in total

1.  1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer.

Authors:  Isabelle Clinckspoor; Lieve Verlinden; Lutgart Overbergh; Christopher Korch; Roger Bouillon; Chantal Mathieu; Annemieke Verstuyf; Brigitte Decallonne
Journal:  J Steroid Biochem Mol Biol       Date:  2010-12-21       Impact factor: 4.292

2.  Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats.

Authors:  T Shinki; Y Ueno; H F DeLuca; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  1,25-Dihydroxyvitamin D3 antagonizes interferon-gamma-induced expression of class II major histocompatibility antigens on thyroid follicular and testicular Leydig cells.

Authors:  N Tokuda; T Mano; R B Levy
Journal:  Endocrinology       Date:  1990-09       Impact factor: 4.736

4.  Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.

Authors:  Lotte Bjerre Knudsen; Lars Wichmann Madsen; Søren Andersen; Kasper Almholt; Anne S de Boer; Daniel J Drucker; Carsten Gotfredsen; Frederikke Lihme Egerod; Anne Charlotte Hegelund; Helene Jacobsen; Søren Dyring Jacobsen; Alan C Moses; Anne-Marie Mølck; Henriette S Nielsen; Jette Nowak; Helene Solberg; Tu D L Thi; Milan Zdravkovic; Ulrik Moerch
Journal:  Endocrinology       Date:  2010-03-04       Impact factor: 4.736

5.  Effect of 22-oxa-1,25-dihydroxyvitamin D3 on human thyroid cancer cell growth.

Authors:  K Okano; T Usa; A Ohtsuru; T Tsukazaki; Y Miyazaki; A Yonekura; H Namba; H Shindoh; S Yamashita
Journal:  Endocr J       Date:  1999-04       Impact factor: 2.349

6.  Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.

Authors:  Isabelle Clinckspoor; Esther Hauben; Lieve Verlinden; Annick Van den Bruel; Lieve Vanwalleghem; Vincent Vander Poorten; Pierre Delaere; Chantal Mathieu; Annemieke Verstuyf; Brigitte Decallonne
Journal:  J Histochem Cytochem       Date:  2012-04-17       Impact factor: 2.479

7.  Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.

Authors:  Wei Liu; Sylvia L Asa; I George Fantus; Paul G Walfish; Shereen Ezzat
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

8.  Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid.

Authors:  S Lee; S Morimoto; T Onishi; M Tsuji; Y Okada; Y Seino; M Ishida; K Yamaoka; S Takai; A Miyauchi; Y Kumahara
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

9.  Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat.

Authors:  T Naveh-Many; J Silver
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

10.  Practical stereological methods for morphometric cytology.

Authors:  E R Weibel; G S Kistler; W F Scherle
Journal:  J Cell Biol       Date:  1966-07       Impact factor: 10.539

View more
  6 in total

Review 1.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Vitamin D deficiency affects thyroid autoimmunity and dysfunction in iodine-replete area: Korea national health and nutrition examination survey.

Authors:  Mijin Kim; Eyun Song; Hye-Seon Oh; Suyeon Park; Hyemi Kwon; Min Ji Jeon; Won Gu Kim; Won Bae Kim; Young Kee Shong; Tae Yong Kim
Journal:  Endocrine       Date:  2017-09-21       Impact factor: 3.633

3.  Thyroid Autoimmunity in the Context of Type 2 Diabetes Mellitus: Implications for Vitamin D.

Authors:  Konstantinos Toulis; Xanthippi Tsekmekidou; Evangelos Potolidis; Triantafyllos Didangelos; Anna Gotzamani-Psarrakou; Pantelis Zebekakis; Michael Daniilidis; John Yovos; Kalliopi Kotsa
Journal:  Int J Endocrinol       Date:  2015-05-19       Impact factor: 3.257

Review 4.  Sunshine vitamin and thyroid.

Authors:  Immacolata Cristina Nettore; Luigi Albano; Paola Ungaro; Annamaria Colao; Paolo Emidio Macchia
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

5.  Vitamin D deficiency in non-autoimmune hypothyroidism: a case-control study.

Authors:  Salma Ahi; Mohammad Reza Dehdar; Naser Hatami
Journal:  BMC Endocr Disord       Date:  2020-03-20       Impact factor: 2.763

6.  Vitamin D3 Treatment Alters Thyroid Functional Morphology in Orchidectomized Rat Model of Osteoporosis.

Authors:  Branka Šošić-Jurjević; Svetlana Trifunović; Jasmina Živanović; Vladimir Ajdžanović; Marko Miler; Nataša Ristić; Branko Filipović
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.